Search
Cardiolipin Biosynthesis CL(a-13:0/i-20:0/i-20:0/i-14:0)[rac]
smpdb.ca/view/SMP0477633MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(a-13:0/i-20:0/i-20:0/i-19:0)[rac]
smpdb.ca/view/SMP0477674MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(a-13:0/i-20:0/i-22:0/i-20:0)[rac]
smpdb.ca/view/SMP0477967MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(i-12:0/i-20:0/i-20:0/a-15:0)[rac]
smpdb.ca/view/SMP0479224MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(i-13:0/i-20:0/a-13:0/i-20:0)[rac]
smpdb.ca/view/SMP0479530MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(i-13:0/i-20:0/a-17:0/i-20:0)[rac]
smpdb.ca/view/SMP0479671MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(i-13:0/i-20:0/i-20:0/a-15:0)[rac]
smpdb.ca/view/SMP0479840MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(i-13:0/i-20:0/i-20:0/a-17:0)[rac]
smpdb.ca/view/SMP0479844MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(a-13:0/i-21:0/i-20:0/i-20:0)[rac]
smpdb.ca/view/SMP0483649MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
ARCoV
go.drugbank.com/drugs/DB15855ExperimentalAs of July 2020, the vaccine candidate is set for Phase 1 clinical trials to investigate for safety, tolerance, and immunogenicity (ChiCTR2000034112).